Regeneron boosts M&A activity with $101.9M spent on in-process R&D in Q1 2026

{
  "signal_id": "15f1db79-690b-4167-b3b0-843a94dceea2",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionAnnounced",
  "detected_at": "2026-05-05T08:48:21.551+00:00",
  "company": {
    "name": "Regeneron",
    "domain": "regeneron.com"
  },
  "data": {
    "detail": "The company dramatically increased spending on acquiring external research assets, from $12.3M to $101.9M year-over-year. This signals an aggressive strategy to bolster its drug pipeline through acquisitions and licensing, which often creates needs for technology integration, data migration, and financial consolidation services.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "Acquired in-process research and development expense for the three months ended March 31, 2026.",
      "dollar_millions": 101.9
    },
    "summary": "Regeneron boosts M&A activity with $101.9M spent on in-process R&D in Q1 2026",
    "excerpts": "Acquired in-process research and development 101.9 [million in Q1 2026] 12.3 [million in Q1 2025]",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/regn-20260331.htm",
    "filing_date": "2026-04-29",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Integration needs coming",
    "signal_category": "strategic"
  }
}

curl https://signals.autobound.ai/v1/signals/15f1db79-690b-4167-b3b0-843a94dceea2 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"regeneron.com","limit":20}'